Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-03 9:19 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Avidity Partners Management LP | 2,930,250 9.900% | 7,427 (+0.25%) | View |
| 2024-11-22 4:41 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | TCG Crossover GP II LLC | 1,501,624 5.100% | 1,501,624 (New Position) | View |
| 2024-11-14 5:48 pm Sale | 13G | DIANTHUS THERAPEUTICS INC DNTH | 5AM Partners VII LLC | 1,027,711 3.500% | -654,873 (-38.92%) | View |
| 2024-11-14 5:47 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Venrock Healthcare Capital Partners III L.P. | 1,744,373 5.900% | 816,667 (+88.03%) | View |
| 2024-11-08 5:31 pm Unchanged | 13G | DIANTHUS THERAPEUTICS INC DNTH | BlackRock Inc. BLK | 1,644,819 5.600% | 0 (Unchanged) | View |
| 2024-10-24 2:02 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | BlackRock Inc. BLK | 1,644,819 5.600% | 1,644,819 (New Position) | View |
| 2024-10-11 4:02 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Octagon Capital Advisors LP | 1,746,667 6.000% | 1,746,667 (New Position) | View |
| 2024-09-12 8:45 pm Unchanged | 13D | DIANTHUS THERAPEUTICS INC DNTH | Viridian LLC | 1,090,283 3.720% | 0 (Unchanged) | View |
| 2024-04-01 6:34 pm Sale | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,957,385 9.990% | -3,362 (-0.11%) | View |
| 2024-02-14 4:58 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | CITADEL ADVISORS LLC | 2,880 0.000% | 2,880 (New Position) | View |
| 2024-02-14 4:16 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | 5AM Partners VII LLC | 1,682,584 5.700% | 200,264 (+13.51%) | View |
| 2024-02-14 4:15 pm Unchanged | 13G | DIANTHUS THERAPEUTICS INC DNTH | Third Rock Ventures IV L.P. | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-09 4:10 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | GV 2016 L.P. | 208,697 1.400% | 208,697 (New Position) | View |
| 2024-02-02 4:32 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | BCLS Fund III Investments LP | 2,992,028 9.990% | 2,992,028 (New Position) | View |
| 2024-02-01 6:22 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA CAPITAL MANAGEMENT L.P. | 2,995,023 9.990% | 2,995,023 (New Position) | View |
| 2024-01-31 12:11 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Avidity Partners Management LP | 2,922,823 9.900% | 2,922,823 (New Position) | View |
| 2024-01-24 5:26 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 2,960,747 9.900% | 1,086,914 (+58.00%) | View |
| 2023-11-13 09:02 am Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | FMR LLC | 2,218,212 14.970% | 2,218,212 (New Position) | View |
| 2023-09-21 4:34 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Viridian LLC | 1,090,283 7.400% | 1,090,283 (New Position) | View |
| 2023-09-21 4:32 pm Purchase | 13D | DIANTHUS THERAPEUTICS INC DNTH | Fairmount Funds Management LLC | 1,873,833 12.700% | 1,873,833 (New Position) | View |